Substance use & misuse · 2025
Prescription and Nonprescription Drug Misuse and Abuse in Jordan: A 15-Year Community Pharmacy Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ali Ruaa, Wazaify Mayyada
Аннотация
BACKGROUND: Prescription and nonprescription drug abuse and misuse are global concerns. Monitoring this issue in community pharmacies is critical for early intervention and management.
OBJECTIVES: This study investigates changes in prescription and nonprescription drug misuse and abuse in Jordan's community pharmacies in 2021 and compares these findings to previous studies from 2006 to 2014.
METHODS: A cross-sectional survey was conducted among community pharmacists across Jordan, with data collected via an online questionnaire.
RESULTS: A total of 459 pharmacists responded, with all suspecting some level of drug abuse/misuse in their practice. Nonprescription products most frequently suspected of being abused included cough and cold medications (23.3%), ophthalmic preparations (20.3%), analgesics (13.7%), sleeping aids (12.9%), and topical corticosteroids (TCS) (7.8%). Prescription drugs most frequently suspected were gabapentin (28.8%), systemic antibiotics (28.3%), pregabalin (17.5%), sedatives/hypnotics (8.6%), and systemic corticosteroids (6.4%). New products, such as gabapentin, TCS, and loperamide, were identified in 2021, while others, like sedatives/hypnotics and anticholinergics, declined or disappeared from the list since 2014.
CONCLUSION: Patterns of suspected drug abuse/misuse in Jordan have shifted, with new drugs emerging and others declining. Understanding these trends is essential for identifying factors that influence drug misuse and abuse and for developing policies to promote safe use in the community pharmacy sector.
OBJECTIVES: This study investigates changes in prescription and nonprescription drug misuse and abuse in Jordan's community pharmacies in 2021 and compares these findings to previous studies from 2006 to 2014.
METHODS: A cross-sectional survey was conducted among community pharmacists across Jordan, with data collected via an online questionnaire.
RESULTS: A total of 459 pharmacists responded, with all suspecting some level of drug abuse/misuse in their practice. Nonprescription products most frequently suspected of being abused included cough and cold medications (23.3%), ophthalmic preparations (20.3%), analgesics (13.7%), sleeping aids (12.9%), and topical corticosteroids (TCS) (7.8%). Prescription drugs most frequently suspected were gabapentin (28.8%), systemic antibiotics (28.3%), pregabalin (17.5%), sedatives/hypnotics (8.6%), and systemic corticosteroids (6.4%). New products, such as gabapentin, TCS, and loperamide, were identified in 2021, while others, like sedatives/hypnotics and anticholinergics, declined or disappeared from the list since 2014.
CONCLUSION: Patterns of suspected drug abuse/misuse in Jordan have shifted, with new drugs emerging and others declining. Understanding these trends is essential for identifying factors that influence drug misuse and abuse and for developing policies to promote safe use in the community pharmacy sector.